drugset / Trial / NCT00174239
Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.
RandomizedParallel-groupDouble-blindTreatment
Summary
The study will assess the relative benefit of cabergoline vs carbidopa/levodopa therapy in treating nighttime problems of Parkinson Disease.
Timeline
- Start
- 2004-07
- Primary completion
- —
- Completion
- 2005-09
Outcome
Outcome not reported
Stopped: “See Detailed Description for termination reason.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cabergoline | Small molecule | — | — |
| Subject | Carbidopa | Unknown | — | — |
| Subject | Levodopa | Unknown | — | — |